OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

@article{Dodick2010OnabotulinumtoxinAFT,
  title={OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program},
  author={D. Dodick and C. Turkel and R. Degryse and S. Aurora and S. Silberstein and R. Lipton and H. Diener and M. Brin},
  journal={Headache: The Journal of Head and Face Pain},
  year={2010},
  volume={50}
}
  • D. Dodick, C. Turkel, +5 authors M. Brin
  • Published 2010
  • Medicine
  • Headache: The Journal of Head and Face Pain
  • (Headache 2010;50:921‐936) 
    583 Citations

    Paper Mentions

    Interventional Clinical Trial
    In this study, the investigators want to investigate whether saline injections in the neck and head muscles can reduce symptoms of chronic migraine. In existing studies, saline… Expand
    ConditionsChronic Migraine
    InterventionDrug, Procedure
    Interventional Clinical Trial
    Onabotulinum toxin type A (BoNT-A) is a potent neurotoxin that has been reported to have an effect on afferent (sensory) neurons independent of its action on muscle tone and secretory… Expand
    ConditionsNeuropathic Pain
    InterventionDrug
    Interventional Clinical Trial
    The purpose of the research is to examine the outcomes of pediatric patients receiving Botulinum toxin type A (Botox ®) for the treatment of migraine. There is limited literature… Expand
    ConditionsHeadache, Migraine, Migraine Disorders, Pediatrics
    InterventionDrug, Other
    OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program
    • 201
    Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial
    • 13
    Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine
    • 9

    References

    SHOWING 1-10 OF 69 REFERENCES
    Placebo response in the prophylaxis of migraine: A meta‐analysis
    • 99
    • PDF
    Economic Burden of Transformed Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
    • 218
    Epidemiology of Chronic Daily Headache in the General Population
    • 645
    Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain
    • 220
    • PDF
    Botulinum Toxin Type A in the Treatment of Chronic Migraine Without Medication Overuse
    • 91